New biochip in development could detect pathogenic markers rapidly

As part of the National Research Council (NRC) Genomics and Health Initiative in Canada, a multidisciplinary scientific team involving several NRC facilities has undertaken a three-year, $17-million project to design biochips to investigate the molecular processes underlying critical infectious diseases, such as E. coli and Listeria monocytogenes. The goal is to create small and efficient point-of-care diagnostic devices integrated onto a single silicon chip. These biochips, in turn, could rapidly detect specific pathogenic markers based on their "genomic signature" in order to diagnose infectious agents that threaten water and food safety, or are responsible for hospital-acquired infections.

So far, the NRC team has configured photonic wires to produce sensitive probes that can measure the molecular properties of biochemical mixtures. Rather than relying on chemicals used in the time-consuming process of fluorescent labeling, NRC's photonic-wire evanescent field (PWEF) sensor-array technology sends light along the interface between the silicon and the liquid sample that sits atop the sensor. If the light encounters a target molecule, such as a piece of DNA or a "marker" molecule belonging to a protein unique to certain bacteria, the passage of the light is altered. This minute change is measured by the sensor's photodetector, which the system interprets as the presence of the target molecule.

NRC researchers are also designing a complementary biochip that uses electrons, instead of light, to detect the presence of pathogens. Ultimately, the PWEF sensor-array and biochip technology could be integrated into a single device. That device would be capable of conducting multiple measurements simultaneously and would provide detailed genotyping of a bacterial strain or other pathogen present in a sample, says Dr. John Pezacki, who serves as scientific leader of the NRC biochips project.

NRC's rapid biosensing technology could be used both in labs that lack efficient and cost-effective diagnostic tools, and for conducting tests in the field. To facilitate field tests, the biochips team is building a portable demonstration system that could be transported to a site for testing.

"It could be used in a food processing plant to take swabs from equipment and check for bacteria, or at a water source where a technician could collect a sample and see whether any pathogens are present," explains Eddy Guzzo, who serves as project manager of the biochips initiative. "There could also be multiple applications in a hospital setting, where the system could be used to test the blood of patients or to take swabs of operating rooms to see if any potentially harmful bacteria are living on any surfaces."

Dr. Pezacki says that if a company commercializes the biosensor alone or in partnership with NRC, the technology platform is broad enough for the biomedical community to adapt it for other applications, such as testing samples for pathogens. "We want to enhance its capabilities in monitoring and surveillance, in partnership with other government agencies."

To that end, NRC is collaborating with the Public Health Agency of Canada (PHAC) to use the biochips technology to identify pathogenic strains of E. coli as part of PHAC's efforts to prevent pandemics and outbreaks of diseases.

Source: National Research Council Canada

Posted by Lee Mather

Follow us on Twitter

Subscribe now to BioOptics World Magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.
BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS